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Objectives Offering antenatal sickle cell and thalassaemia (SCT) screening early in pregnancy can
maximize the range of post-screening choices available, however these beneﬁts should not be
obtained at the expense of informed choice. This study examined whether offering this screening
in primary care at the time of pregnancy conﬁrmation compromises women making informed choices.
Design Partial factorial, cluster randomized controlled trial.
Setting 25 general practices in two socially deprived UK areas.
Participants 464 pregnant women offered antenatal SCT screening.
Intervention Practices were randomly allocated to offer pregnant women screening: i) in primary
care at time of pregnancy conﬁrmation, with parallel partner testing (n ¼ 191), ii) in primary care at
time of pregnancy conﬁrmation, with sequential partner testing (n ¼ 158), or iii) in secondary care by
midwives, with sequential partner testing (standard care, n ¼ 115).
Main outcome Informed choice – a classiﬁcation based on attitudes, knowledge and test uptake.
Results 91% of woman underwent screening. About a third (30.6%) made an informed choice to
accept or decline screening: 34% in primary care parallel group; 23.4% in primary care
sequential and 34.8% in secondary care sequential. Allowing for adjustments, rates of informed
choice did not vary by intervention group: secondary care versus primary care with parallel
partner testing OR 1.07 (95% CI 0.56 to 2.02); secondary care versus primary care with
sequential partner testing OR 0.67 (95% CI 0.36 to 1.25). Uninformed choices were generally
attributable to poor knowledge (65%).
Conclusion Offering antenatal SCT screening in primary care did not reduce the likelihood that
women made informed choices. Rates of informed choice were low and could be increased by
improving knowledge.
INTRODUCTION
T
here is a consensus that choices made about under-
going antenatal screening for fetal abnormalities
should be informed.
1–3 Research on the factors
associated with informed choice for people making health-
care choices has tended to assess one dimension only,
most often knowledge about a procedure. It is now widely
acknowledged that informed choice is more complex than
this and involves several dimensions. A consensus is emer-
ging that informed choices have two core characteristics:
ﬁrst, they reﬂect an individual’s values, and second, they
are made in the context of good knowledge. An informed
choice has been deﬁned as:
A decision based on relevant knowledge, consistent with the
decision-maker’s values and behaviourally implemented.
4
Thus, an informed choice to accept screening is one based on
good knowledge where those with positive attitudes towards
undergoing screening accept it; an informed choice to
decline screening is one based on good knowledge where
those with negative attitudes towards undergoing screening
decline it. Choices based on poor knowledge or which are
inconsistent with attitudes towards undergoing the screen-
ing test are classiﬁed as uninformed.
Many factors have been identiﬁed as important in limiting
the opportunity for couples to make informed choices in the
context of antenatal screening for sickle cell and thalassae-
mia (SCT). These include: failure to offer screening or
screening offered too late in pregnancy; women’s lack of
knowledge about the screening test; the screening process
taking too long; and diagnostic testing offered too late in
pregnancy.
5,6 In 2001 a national antenatal screening pro-
gramme for sickle cell and thalassaemia in England was set
up. Pregnant women are informed about the screening
tests by their midwife, and this discussion is supported by
written materials produced nationally (http://sct.screening.
nhs.uk/publications). In the study sites a universal screening
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for both sickle cell and thalassaemia using a single blood
sample (testing for routine red cell indices and haemoglobin
variants allows identiﬁcation of both disorders).
Offering screening early in pregnancy has the potential to
maximize early uptake and the range of reproductive
choices, including prenatal diagnostic testing (PND) for at-
risk couples (where bothparentsarecarriersofthecondition),
and the choice of termination of affected pregnancies. The
target is to offer screening by 8–10 weeks gestation, but this
rarelyhappens.
2,7Theearlieststageatwhichantenatalscreen-
ingcanbeoffered,practically,isatthepregnancyconﬁrmation
consultation in primary care. However, some characteristics of
GPs’ primary care consultations may impede the facilitation of
informed choices. The duration and context of the primary
care pregnancy conﬁrmation consultation is perhaps less con-
ducive to facilitating informed choices than is the booking
appointment conducted by a midwife. GPs have less time
than midwives for their ﬁrst consultation with a pregnant
woman. Further, women booking with a midwife may have
had their pregnancies conﬁrmed several weeks earlier, and
are therefore more likely than women just conﬁrming their
pregnancies to be primed to receive, retain and process infor-
mationregardingantenatalcare.Thisstudyexamineswhether
offering antenatal SCT screening inprimary care at the timeof
pregnancyconﬁrmationcompromisesthemakingofinformed
choices. This is part of a trial examining the effectiveness,
acceptability and feasibility of offering screening in primary
care. The trial took place in areas with high prevalence of
sickle diseases and thalassaemia, due to their large black and
minority ethnicity communities. We report separately that
offering screening in primary care results in screening taking
place earlier in pregnancy than when screening is offered by
midwives in community-based secondary care.
7
METHODS
Design
A partial factorial cluster randomized controlled trial design
was used to assess rates of informed choice in women
offered antenatal SCT screening.
7
Setting and randomization
The study was conducted in 25 practices from two UK inner-
city PCTs, ranked sixth and thirteenth most deprived of the
354 PCTs in England,
8 with about 40% of their populations
from minority ethnic groups. Antenatal SCT screening was
offered to all women regardless of ethnicity during the
study period.
9 The standard pattern of care at the time of
the study was for women to be offered screening at their
ﬁrst midwife appointment (at about 12–15 weeks gestation).
Practices were allocated to one of three study groups:
Primary Care Parallel: Screening offered to the woman and
her baby’s father simultaneously at the ﬁrst consultation to
conﬁrm pregnancy in primary care (analogous to couple
screening in antenatal screening for cystic ﬁbrosis). If the
baby’s father did not attend with the mother at the ﬁrst con-
sultation, then she received a testing information pack to
give to him.
Primary Care Sequential: Screening offered to the woman at
the ﬁrst consultation to conﬁrm pregnancy in primary care,
screening subsequently offered to the baby’s father only if
the woman is identiﬁed as a carrier.
Secondary Care Sequential: Screening offered to the woman
at her ﬁrst midwife appointment (booking appointment) in
community-based secondary care, screening subsequently
offered to the baby’s father only if the woman is identiﬁed
as a carrier.
SCT screening involves testing a blood sample from the
parent. Women wishing to be screened had this sample
taken in accordance with the procedures operating where
the test was offered. In some practices an in-house phlebot-
omy service was available (n ¼ 10) and in others women
were required to attend a local phlebotomy centre (n ¼ 15).
Health-care professionals were trained to facilitate informed
choice about SCT screening, through a teaching session on
key points to be communicated to the patient, a chance to
practice what they had learned in a simulated consultation
with an actor playing the patient, and a question-and-answer
session with a local Sickle Cell counsellor.
10 This discussion
was supported by written materials produced nationally by
the National Screening Committee and NHS Sickle Cell and
Thalassaemia Screening Programme (http://sct.screening.
nhs.uk/publications). The study information leaﬂet did not
provide anyadditional information on the screening test itself.
Randomization
Studypracticeswereallocatedtointerventiongroupsafterthey
hadagreedtoparticipateandenteredtherun-indatacollection
period (when data on pre-trial gestational age at screening
were collected). The allocations for 27 practices (two practices
withdrew from the study before the intervention started)
were determined independently by the trial statistician, in
three batches, using minimization;
11 stratifying for the two
primary care organizations and number of family physician
partners at the practice (one or two versus three or more).
Participants
Women eligible to complete assessments of informed choice
comprised those who attended a participating practice to
report their pregnancies and:
– planned to continue their pregnancies
– were less than orequal to 19 weeks and six days gestation
at their consultation to conﬁrm pregnancy in primary
care (based on self-reported last menstrual period)
– for whom there was no written record of sickle cell and
thalassaemia carrier status in primary care
– were aged 18 or over
– agreed to be contacted by the research team.
Women who miscarried before being contacted by the
research team were also excluded.
Responserate
Therewere993eligiblewomenwhoagreedtobecontactedby
the researchteam.Ofthesewomen, 727 (73%) agreed to take
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Completed questionnaires were obtained from 464 (68%)
women who met the eligibility criteria for the main analysis.
Outcome measures
The questionnaires used in this study (see Appendix 1) were
developed for use in populations with low levels of literacy.
12
Knowledge: This 10-item scale (questions 5–16 in Appendix
1)assessed knowledge in the mainareas deemedimportant in
professional guidelines for informed consent for screening,
13
made speciﬁc to screening for sickle cell and thalassaemia.
The alpha coefﬁcient of internal reliability in this sample was
0.66. Non-responses for knowledge were coded as incorrect.
Good and poor knowledge were deﬁned by the midpoint of
the scale, with scores greater than ﬁve denoting good knowl-
edge. There is no absolute standard of good knowledge – it
could be argued that only answering all questions correctly
constitutes good knowledge. The decision to use scores
greater than ﬁve is a pragmatic one.
Attitudes towards undergoing the test: This scale consisted of
four items (items 1–4 in Appendix 1, each scored 0 to 6,
scale score range 0 to 24), assessing the extent to which
women perceive undergoing SCT screening themselves
(not SCT screening per se) positively or negatively. The
alpha coefﬁcient of internal reliability in this sample was
0.70. As there were four questions, the scale mid-point rep-
resents the split between positive and negative responses;
positive and negative attitudes were therefore deﬁned by
the midpoint of the scale, with scores greater than 11 denot-
ing positive attitudes towards undergoing screening and
scores of 11 or less denoting negative attitudes towards
undergoing screening.
Screening uptake: This was extracted from laboratory
records.
Informed choice: Choices about antenatal SCT screening
were classiﬁed as informed or uninformed according to
women’s knowledge about antenatal SCT screening, their
attitudes towards undergoing screening and whether or
not they underwent screening. Women with positive atti-
tudes towards undergoing screening (attitude score greater
than 11) and good knowledge (knowledge score greater
than ﬁve) who underwent antenatal SCT screening, were
classiﬁed as making an informed choice to undergo screen-
ing. Women with negative attitudes and good knowledge
who did not have screening, were classiﬁed as making an
informed choice to decline screening. Other choices were
classiﬁed as uninformed. There is good evidence to support
the validity of this classiﬁcation.
4,12 Total rates of informed
choice were calculated by summing the number of women
who made an informed choice to accept screening with
the number who made an informed choice to decline the
screening test.
Demographicdetails
Participants provided their date of birth, gestation at time of
questionnaire completion and highest level of education.
Information on parity and ethnicity was obtained from GP
practices. Neighbourhood levels of deprivation data were esti-
mated from post codes to which study materials were sent.
14
Procedure
Ethical approval was granted for the trial (05/Q0501/36).
Women were verbally informed of the study and provided
with a study information leaﬂet (in their own language) by
the attending health-care professional at their ﬁrst visits to
conﬁrm their pregnancy in primary care. Women were
asked to verbally consent to their contact details being given
to the research team. A female researcher contacted those
agreeing to this, by telephone in the ﬁrst instance, to seek
informed consent to participate. Consenting women were
invited to complete questionnaires on the telephone or by
post. Up to two reminders were sent together with a question-
naire. Women with a preferred language other than English
were invited to complete the questionnaire in the language
of their choice. Twenty languages other than English were
used in telephone translations and nine languages other
than English were used in written translations. About half of
the women completed the questionnaire after they had pro-
vided a blood sample for the screening test.
A choice of telephone or postal completion was offered in
order to achieve higher response rates. Telephone com-
pletion compared with postal completion allows for ready
translation to more languages and provides social support
to complete the questionnaire.
15 Perhaps most importantly
it removes the reading obstacle to questionnaire completion
thereby allowing the estimated 20–25% of the UK popu-
lation who are functionally illiterate
16 to participate in the
research process.
Data analysis
Proportions and medians (with interquartile ranges), for atti-
tude and knowledge scores and for informed choice, were
tabulated by study group. Inﬂuence of study group on each
of these variables was assessed using logistic (non-linear
outcome variable) or linear regression (linear outcome vari-
able) of the variable on study group using robust standard
errors to allow for clustering by practice. Logistic regression
was used to estimateodds ratiosand theirconﬁdence intervals
formakinganinformedchoicebystudygroup.Multiplelinear
regression was used to identify independent predictors of
knowledge. In both analyses, adjustment was made for age
group, parity, ethnicity, education, Indices of Multiple
Deprivation (IMD) score, language (English or translated)
and method of questionnaire completion.
RESULTS
Characteristics ofthesample
Table 1 summarizes the demographic characteristics of women
in each of the three trial arms. The groups did not differ on
parity, IMD 2004 score, educational level, age, method of com-
pletion or use of translated questionnaires. Signiﬁcant differ-
ences were observed in ethnicity and the gestation at which
questionnaires were completed. For the Primary Care
Sequential group, 48.7% were described as Asian, in compari-
sonwith22%inPrimaryCareParalleland28.7%inSecondary
Care Sequential. For the Primary Care Parallel group, 34.6%
were African/African Caribbean ethnicity, in comparison
with 15.2% in Primary Care Sequential and 21.7% in
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questionnaires was eight weeks (7–11) for Primary Care
Parallel, nine weeks (8–12) for Primary Care Sequential, and
18 weeks (16–21) for Secondary Care Sequential.
Rates of informed choice and method oftest offer
Less than a third of women made an informed choice to
accept or decline screening (30.6%) (Table 2). Attitudes
towards undergoing antenatal SCT screening were strongly
positive and did not vary by trial arm (P ¼ 0.55). The pro-
portion of women with positive attitudes was 96.3% for
Primary Care parallel, 94.3% for Primary Care Sequential
and 96.5% for Secondary Care Sequential. The mean differ-
ence between the Primary Care Sequential and Primary Care
Parallel arms was 20.20 (95% conﬁdence interval: 2.65 to
0.45, P ¼ 0.708). The mean difference between the
Secondary Care Sequential and Primary Care Parallel arms
Table1 Demographic characteristics
Primary Care
Parallel (n ¼ 191)
Primary Care
Sequential (n ¼ 158)
Secondary Care
Sequential (n ¼ 115)
a
P value for between-
group comparison
Primiparae
† 61.3 57.0 58.3 0.83
IMD score
‡ 39.7 (32.3 to 49.2) 35.9 (28.7 to 41.7) 36.2 (31.4 to 43.7) 0.11
Highest educational qualiﬁcation
†
No qualiﬁcation 7.9 8.9 9.6 0.06
GCSE or similar 15.7 20.9 22.6
GCE A-level or similar 14.1 16.5 7.0
Further education or similar 20.9 17.1 20.9
Degree or similar 38.7 35.4 37.4
Missing 2.6 1.3 2.6
Age at completion of
questionnaire
(years)
‡
28.2 (24.2 to 31.3) 28.4 (25.9 to 33.2) 30.0 (25.0 to 33.6) 0.173
Gestation at completion of
questionnaire (weeks)
‡
8 (7 to 11) 9 (8 to 12) 18 (16 to 21) ,0.001   
Practice-reported ethnic group
†
Asian 22.0 48.7 28.7 ,0.001   
African/African Caribbean 34.6 15.2 21.7
North European 10.0 6.3 13.9
South European 5.2 3.8 8.7
Other 24.1 20.9 21.7
Mixed 2.6 2.5 3.5
Not recorded 1.6 1.3 0.9
Other non-North European 0.0 1.3 0.9
Questionnaire completed on
telephone
†
88.0 84.2 83.5 0.71
Questionnaire translated
† 16.2 27.2 17.4 0.24
aone case had missing values for informed choice and attitude;
†%;
‡median (interquartile range);    P , 0.001
Table 2 Attitudes, knowledge, screening uptake and informed choice among women
Primary Care
Parallel
(n ¼ 191)
Primary Care
Sequential
(n ¼ 158)
Secondary Care
Sequential
(n ¼ 115)
a
All
(n ¼ 464)
P value for
between-group
comparison
Making an informed choice
† 34.0 23.4 34.8 30.6 0.38
Uninformed choice, poor knowledge
† 62.8 72.1 60.0 65.3 0.47
Uninformed choice, attitude-behaviour
inconsistent
†
3.1 4.4 5.2 4.1 0.75
Uptake
† 92.7 91.1 87.0 90.7 0.45
Attitude median score
(0–24, higher score ¼ more positive
attitude)
‡
23 (20–24) 23 (19–24) 24 (20–24) 23 (20–24) 0.55
Proportion with positive attitudes
† 96.3 94.3 96.5 95.7 0.60
Proportion acting consistently with
attitudes: POSITIVE attitude,
TESTED
†† †
93.5 (172/184) 93.3 (139/149) 88.3 (98/111) 92.1 (409/444) 0.44
Proportion acting consistently with
attitudes: NEGATIVE attitude, NOT
TESTED
†† †
29 (2/7) 44 (4/9) 50 (2/4) 40 (8/20) 0.81
Knowledge median score
(0–10, higher score ¼ better
knowledge)
‡
5 (3–6) 4 (2–6) 5 (3–6) 4 (3–6) 0.33
Proportion with good knowledge
† 37.2 27.9 40.0 34.7 0.47
aone case had missing values for informed choice and attitude;
†%;
††n/N;
‡median (interquartile range)
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women acted consistently with their positive attitudes
towards undergoing screening in that they underwent
screening. Knowledge was low and did not vary by trial
arm. Screening uptake did not vary by trial arm. The relative
odds of screening uptake in the Primary Care Sequential
arm, compared with the Primary Care Parallel arm, were
0.81 (95% conﬁdence interval 0.36 to 1.82, P ¼ 0.616);
the relative odds for the Secondary Care Sequential arm,
compared with Primary Care Parallel, were 0.53 (0.20 to
1.42, P ¼ 0.205). Rates of informed choice did not vary by
trial arm. The relative odds of an informed choice in the
Primary Care Sequential arm, compared with the Primary
Care Parallel arm, were 0.59 (0.26 to 1.36, P ¼ 0.219); the
relative odds for the Secondary Care Sequential arm, com-
pared with Primary Care Parallel, were 1.03 (0.49 to 2.17,
P ¼ 0.930). The majority of choices were classiﬁed as unin-
formed because of poor knowledge (65.3%), and not
because woman acted inconsistently with their attitudes
(4.1%). Women knew most about options following ante-
natal diagnosis and sickle cell disease, and least about thalas-
saemia and inheritance of the conditions.
Predictors of making an informed choice
Education, age, language of questionnaire completion and
ethnicity were all signiﬁcant predictors of making an
informed choice (Table 3). Failure to disclose education (OR
11.39, 95% CI 1.62 to 80.2), having a degree (OR 7.30,
95% CI 1.37 to 38.9), or being educated to GCSE/A-level/
Further education (OR 6.26, 95% CI 1.25 to 31.3) versus
no education, were the strongest predictors of making an
informed choice. Being in the oldest age category (OR 2.84,
95% CI 1.23 to 6.57) was the next strongest predictor.
Having the questionnaire translated (OR 0.13, 95% CI 0.05
to 0.36) or being from a high-risk ethnic group (OR 0.50,
95% CI 0.26 to 0.93) predicted an uninformed choice.
Predictors of good knowledge
Older age, more education and telephone questionnaire
completion all predicted better knowledge. Having the ques-
tionnaire translated predicted poorer knowledge (Table 4).
DISCUSSION
Being offered antenatal SCT screening in primary care at the
time of pregnancy conﬁrmation did not undermine women
making informed choices. Women were as likely to make an
informed choice when the test was offered in primary care
as when it was offered by midwives later in pregnancy.
However, less than one-third of women made an informed
choice about screening. This is much lower than has been
observed in the context of other antenatal screening
tests.
17–19 This may be because among health-care pro-
fessionals, pregnant women and their families awareness
of sickle cell and thalassaemia, and of screening for these
conditions, is lower than awareness of Down syndrome.
Almost all uninformed choices were classiﬁed as such
because of poor knowledge, rather than because of inconsis-
tency between attitudes and behaviour. The proportion of
women with good knowledge in the present study was
also lower than that observed in the context of Down syn-
drome screening.
17–19 This may be because levels of neigh-
bourhood deprivation were greater in the current sample or
because greater effort was made to include people who did
not speak English and are often excluded from the research
process. Alternatively, knowledge of sickle cell and thalas-
saemia may be poorer than knowledge of Down syndrome.
Asking the baby’s father to be tested (parallel partner testing
arm – Group 1) was not associated with better knowledge, a
somewhat surprising result given tests for fathers during
pregnancy are uncommon and so this unusual request was
expected to prompt better information provision from
health-care professionals or more questioning from mothers
Table 3 Predictors of women making an informed choice
Relative odds of making
an informed choice (OR) 95% C.I. P Value
Age (years) ,24 1.00 –
24–27.9 1.13 (0.46 to 2.77) 0.793
28–31.9 2.02 (0.96 to 4.25) 0.063
 32 2.84 (1.23 to 6.57) 0.014 
Not known 1.04 (0.16 to 6.84) 0.971
Parity Multiparous 1.00 –
Primiparous 1.30 (0.81 to 2.10) 0.282
Ethnicity Low risk 1.00 –
High risk 0.50 (0.26 to 0.93) 0.030 
Education None 1.00 –
GCSE/A-level/Further Ed. 6.26 (1.25 to 31.3) 0.025 
Degree or above 7.30 (1.37 to 38.9) 0.020 
Not known 11.39 (1.62 to 80.2) 0.015 
IMD 2004 score 0.99 (0.97 to 1.02) 0.6481
QR language English 1.00 –
Translated 0.13 (0.05 to 0.36) ,0.001   
Completion method Postal 1.00 –
Telephone 2.03 (0.93 to 4.44) 0.077
Study group Secondary Care Sequential 1.00 –
Primary Care Parallel 1.07 (0.56 to 2.02) 0.843
Primary Care Sequential 0.67 (0.36 to 1.25) 0.212
 P , 0.05;    P , 0.001
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good and bad knowledge as above or below the scale mid-
point (which was also the sample median). If the cut-off
for good knowledge was higher, even fewer women would
have made an informed choice.
Levels of informed choice in this sample did not appear to
be undermined by attitude-behaviour inconsistency, that is,
the great majority of women who had a positive attitude
towards undergoing testing did so. Scores above the scale
midpoint were deﬁned as positive attitudes because a
marked positive skew in attitudes meant very few partici-
pants would fall into the negative category were a median
split applied. The ﬁndings must therefore be interpreted in
light of this analytic decision.
Being educated to degree level, being older and being in a
low-risk ethnic group were all signiﬁcant predictors of
making an informed choice and (with the exception of eth-
nicity) of having good knowledge. Patient characteristics
have been shown to predict the amount and type of infor-
mation provided by health-care professionals, with patients
of lower socioeconomic status,
20 younger patients,
21,22 and
patients from minority ethnic groups
23 being less likely to
receive adequate information. It is not possible to ascertain
from the current study whether less educated, younger
women from minority ethnic groups were less likely to
make informed choices because of limited information pro-
vision at the point of screening offer, or because of the way
in which those women went on to process that information.
Theeffectofmethodofquestionnairecompletiononknowl-
edge may be explained by the greater tendency among postal
responders than telephone responders to answer ‘don’t
know’, observed in this sample and elsewhere.
15,24
There isevidence that whilst women willaccept professional
adviceaboutscreening,theyareverykeentobeofferedachoice
and to be given information about antenatal screening to
inform that choice.
25–27 It may be that informed choice in the
context of sickle cell and thalassaemia screening would be
achieved if the screening test were offered pre-conceptually
(by screening for haemoglobin variants before a pregnancy
occurs, as is routine practice in some countries).
10,28,29 After
adjustment there was no difference in rates of informed
choices across the three trial arms. There is therefore no evi-
dencefromthistrial that offeringthetest inprimaryorsecond-
arycareresults indifferingrates of informedchoices. However,
offering the test in primary care increases the proportion of
women screened by 8–10 weeks.
7
Strengthsand limitations
This study assessed knowledge and attitudes towards under-
going antenatal SCT screening in a socioeconomically, ethni-
cally and linguistically diverse sample. The study sample is
representative of populations in geographical areas where
antenatal SCT screening is offered routinely to all pregnant
women, and, as such, provides an ecologically valid estimate
of the impact that screening in primary care may have on
rates of informed choice. The suboptimal (though above
average for a study of this population) questionnaire response
rate of 66% may have biased our results. Response rates were
similar amongst randomization groups, so this is unlikely to
have biased our main comparison. Given that non-responders
are likely to have poorer knowledge than responders, we have
probably overestimated rates of informed choice.
The study was designed to allow an estimate of the
proportions making an informed choice in each group
within 10%, with 95% conﬁdence, allowing for clustering.
However, the achieved sample size was smaller than antici-
pated, while the intraclass correlation coefﬁcient by general
practice for the measure of informed choice was higher than
expected (0.089). We acknowledge that the study had
limited power to detect modest differences that might have
been of clinical importance. Whilst the point estimates
suggest a slightly lower proportion making informed choices
Table 4 Predictors of women’s knowledge
Relative odds of having
good knowledge (OR) 95% C.I. P Value
Age (years) ,24 0
24–27.9 0.32 (20.33 to 0.96) 0.318
28–31.9 0.83 (0.19 to 1.47) 0.013 
 32 0.94 (0.23 to 1.64) 0.011 
Not known 20.09 (21.87 to 1.70) 0.919
Parity Multiparous 0
Primiparous 20.12 (20.27 to 0.51) 0.529
Risk based on ethnicity Low SCT risk 0 –
High SCT risk 20.51 (21.03 to 0.04) 0.051
Highest educational qualiﬁcation No qualiﬁcation 0
GCSE/A-level/Further Education 0.66 (20.11 to 1.42) 0.087
Degree or above 1.36 (0.54 to 2.18) 0.002  
Not known 0.90 (20.21 to 2.01) 0.133
IMD 2004 score 20.02 (20.04 to 0.01) 0.114
QR language English 0
Translated 22.10 (22.65 to 21.56) 0.001  
Completion method Postal 0
Telephone 1.07 (0.43 to 1.71) 0.002  
Study group Secondary Care Sequential 0
Primary Care Parallel 0.11 (20.43 to 0.66) 0.667
Primary Care Sequential 20.35 (20.81 to 0.10) 0.120
 P , 0.05;   P , 0.01
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chance ﬁnding as the conﬁdence intervals were wide and
therewasnoappreciable evidenceagainst the nullhypothesis.
Although it was not feasible to extend this study, we have no
reason to expect that, were the sample size increased, primary
caresequentialtestingwouldemergeassigniﬁcantlyworsefor
informed choice than either primary care parallel testing or
secondary care sequential testing.
Training was provided to health-care professionals in facil-
itating informed choice,
10 but the quality of communication
between health-care professionals and pregnant women was
not independently assessed. Alongside the impact of train-
ing, health-care professionals’ attitudes to screening may
affect whether their patients make informed choices,
30,31
however the evidence is mixed and mainly in relation to
antenatal Down syndrome screening. More research is
required to explore the relationship between health pro-
fessional training, attitudes and facilitation of informed
choice in the context of haemoglobinopathies.
This study does not assess the effect of making an informed
choice on outcomes such as prenatal diagnosis (PND) uptake
or termination uptake. We estimate an adequately powered
study to answer this question would require a sample size
equivalent to the pregnant population of England for one
year, and as such was not feasible as part of this trial.
Implications for practice
Whilst most women in this sample were keen and able to
undergo antenatal SCT screening, a sizeable proportion did
so in the context of poor knowledge. Poor knowledge
undermines informed choices and increases the likelihood
of anxiety in those who are identiﬁed as carriers.
32,33,34
While providing written information about screening tests
increases knowledge,
29 increasing knowledge in those with
low levels of education is more effectively achieved if those
providing information also check understanding, and
clarify areas not understood.
35 Decision aids which help
parents to consider their values and preferences whilst also
providing information may be effective in this context.
36
Conclusion
Offering antenatal SCT screening in primary care, at the time
of pregnancy conﬁrmation, did not compromise women
making informed choices. Rates of informed choice were
low for all participants. Efforts to improve rates of informed
choice should focus on improving knowledge, particularly in
those with low levels of education and whose ﬁrst language
is not English.
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APPENDIX1:
Questionnaireused in thestudy
Section1
(1) For me, having the antenatal blood test to ﬁnd out if I
am a carrier for sickle cell or thalassaemia would be:
(2) For me, having the antenatal blood test to ﬁnd out if I
am a carrier for sickle cell or thalassaemia would be:
(3) For me, having the antenatal blood test to ﬁnd out if I
am a carrier for sickle cell or thalassaemia would be:
(4) For me, having the antenatal blood test to ﬁnd out if I
am a carrier for sickle cell or thalassaemia would be:
Note: Please check that you have circled a number for
EACH of the above four questions.
(5) Antenatal screening for sickle cell and thalassaemia is
a blood test that...
(tick 3 only 1 answer to this question)
72 Brown et al.
Journal of Medical Screening 2011 Volume 18 Number 2(6) How likely do you think it is that your baby might be
affected by sickle cell or thalassaemia
(tick 3 only 1 answer to this question)
(7) A baby can be affected by sickle cell or thalassaemia
if...
(tick 3 only 1 answer to this question)
(8) Sickle cell anaemia is
(tick 3 only one answer to this question)
(9) Thalassaemia major is
(tick 3 only one answer to this question)
(10) People with sickle cell anaemia
(you can tick 3 more than one answer to this ques-
tion)
-
(11) People with thalassaemia major
(you can tick 3 more than one answer to this ques-
tion)
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Journal of Medical Screening 2011 Volume 18 Number 2(12) Genes for sickle cell disorders are more common in
people whose family origins are:
(you can tick 3 more than one option)
(13) Genes for thalassaemia disorders are more common in
people whose family origins are:
(you can tick 3 more than one option)
(14) If your results show that you have inherited a gene for
sickle cell or thalassaemia, how likely do you think it
is that your baby will be affected?
(tick 3 only 1 answer to this question)
(15) Some women are offered special tests after they have
been screened for sickle cell or thalassaemia. These
tests are called amniocentesis and chorionic villus
sampling (CVS).
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Journal of Medical Screening 2011 Volume 18 Number 2(16) If the special tests show that the baby has sickle cell or
thalassaemia, the parents are offered counselling. The
options available include:
(you can tick 3 more than one answer)
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